Wound Retraction System Fights Surgical Infections
|
By HospiMedica International staff writers Posted on 27 Dec 2017 |

Image: The CleanCision retraction system combines wound protection and irrigation (Photo courtesy of Prescient Surgical).
An intuitive retraction system utilizes active cleansing technology to consistently and continuously clear harmful bacteria that may invade the incision during surgery.
The Prescient Surgical (San Carlos, CA, USA) CleanCision wound retraction and protection system is a sterile, single-use irrigating wound device that integrates surgical retraction, wound barrier protection, and fluid delivery and removal to protect against surgical site infections (SSIs). The wound barrier protection part is made of a flexible, double-walled sheath with an impermeable inner layer that protects wound edges from contamination. The same sheath provides integrated fluid delivery via gravitational feed to the wound edges through the permeable outer layer of the sheath.
The wound retraction component is formed by attaching the double-walled sheath to a fixed-diameter ring at the bottom, which is inserted into the abdominal cavity, and to an adjustable-diameter radial retraction ring at the top, which is designed to remain outside of the body and actuated to complete wound retraction. The excess irrigation fluid is removed through the bottom ring via connection to a standard vacuum suction mechanism. The CleanCision system has been approved by the U.S. Food and drug Administration (FDA).
“We are initially focusing on abdominal surgery and particularly colorectal surgery, where the risk, frequency, and severity of surgical site infection is high and the need is acute,” said Jonathan Coe, co-founder, president, and CEO of Prescient Surgical. “Our team collaborated closely with leading hospitals in abdominal surgery to create a technology platform and product that could be used in the full range of open and minimally invasive approaches utilized in their procedures.”
“While infection control workflow and processes steadily improve year after year, the tools and technologies that should aid those efforts simply haven't kept pace,” said Insoo Suh, MD, co-founder of Prescient Surgical. “A proactive approach to clearing contamination during surgery has the potential to better protect patients from infection, and help hospitals address the increased health care costs that result from surgical site infections, such as extended hospital stays, re-hospitalization, and rising infection rates that trigger penalties from CMS.”
SSIs are an important source, and may even be the most frequent healthcare-associated infection (HAI) after asymptomatic bacteriuria, representing a high burden on patients and hospitals in terms of morbidity, mortality, prolonged length of hospital stay, and additional costs. Each year, approximately 500,000 surgical patients develop SSIs.
Related Links:
Prescient Surgical
The Prescient Surgical (San Carlos, CA, USA) CleanCision wound retraction and protection system is a sterile, single-use irrigating wound device that integrates surgical retraction, wound barrier protection, and fluid delivery and removal to protect against surgical site infections (SSIs). The wound barrier protection part is made of a flexible, double-walled sheath with an impermeable inner layer that protects wound edges from contamination. The same sheath provides integrated fluid delivery via gravitational feed to the wound edges through the permeable outer layer of the sheath.
The wound retraction component is formed by attaching the double-walled sheath to a fixed-diameter ring at the bottom, which is inserted into the abdominal cavity, and to an adjustable-diameter radial retraction ring at the top, which is designed to remain outside of the body and actuated to complete wound retraction. The excess irrigation fluid is removed through the bottom ring via connection to a standard vacuum suction mechanism. The CleanCision system has been approved by the U.S. Food and drug Administration (FDA).
“We are initially focusing on abdominal surgery and particularly colorectal surgery, where the risk, frequency, and severity of surgical site infection is high and the need is acute,” said Jonathan Coe, co-founder, president, and CEO of Prescient Surgical. “Our team collaborated closely with leading hospitals in abdominal surgery to create a technology platform and product that could be used in the full range of open and minimally invasive approaches utilized in their procedures.”
“While infection control workflow and processes steadily improve year after year, the tools and technologies that should aid those efforts simply haven't kept pace,” said Insoo Suh, MD, co-founder of Prescient Surgical. “A proactive approach to clearing contamination during surgery has the potential to better protect patients from infection, and help hospitals address the increased health care costs that result from surgical site infections, such as extended hospital stays, re-hospitalization, and rising infection rates that trigger penalties from CMS.”
SSIs are an important source, and may even be the most frequent healthcare-associated infection (HAI) after asymptomatic bacteriuria, representing a high burden on patients and hospitals in terms of morbidity, mortality, prolonged length of hospital stay, and additional costs. Each year, approximately 500,000 surgical patients develop SSIs.
Related Links:
Prescient Surgical
Latest Surgical Techniques News
- Ultrasound Technology Aims to Replace Invasive BPH Procedures
- Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
- New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
- Robot-Assisted Brain Angiography Improves Procedural Outcomes
- Brain Mapping Technology Enhances Precision in Brain Tumor Resection
- Handheld Robotic System Expands Options for Total Knee Surgery
- VR Experience Reduces Patient Anxiety Before Kidney Stone Procedure
- Injectable Mini Livers Offer Hope for Patients Awaiting Transplant
- Pulsed Field Ablation Technology Cleared in Europe for Persistent AFib
- AI-Powered Imaging Brings Real-Time Margin Clarity to Breast Cancer Surgery
- Minimally Invasive Device Safely Treats Challenging Brain Aneurysms
- Surgical Robot Makes Complex Liver Tumor Surgery Safer and Less Invasive
- Neurostimulation Implant Reduces Seizure Burden in Drug-Resistant Epilepsy
- Minimally Invasive Procedure Effectively Treats Small Kidney Cancers
- Fluorescence Probe Paired with Engineered Enzymes Lights Up Tumors for Easier Surgical Removal
- Novel Hydrogel Could Become Bone Implant of the Future
Channels
Artificial Intelligence
view channelAI Analysis of Pericardial Fat Refines Long-Term Heart Disease Risk
Accurately identifying long-term cardiovascular disease risk in asymptomatic adults remains challenging for clinicians. Missed or underestimated risk delays preventive therapy and increases the chance... Read more
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read moreCritical Care
view channel
Noninvasive Monitoring Device Enables Earlier Intervention in Heart Failure
Hospitalizations for heart failure with preserved ejection fraction (HFpEF) remain common because lung congestion often worsens before symptoms prompt treatment changes. Missed early decompensation... Read more
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







